Eye103

2 trials

Filter these 2 trials by condition, phase, country and more.

Open in Search →

2 Registered trials

0 Recruiting

2 Completed trials

1 Sponsors

12 Countries

Phase II/III

Phase II/III: 2

Sponsors using this IMP

Eyebiotech Limited 2

All trials

2 total

A randomized study to evaluate the Efficacy and Safety of Intravitreal EYE103 Compared to Anti-VEGF Ended

2025-520809-12-00 Phase II/III 12 countries Eyebiotech Limited
A randomized study to evaluate the Efficacy and Safety of Intravitreal EYE103 Compared to Anti-VEGF (in patients with Diabetic Macular Edema… Ended

2024-510944-30-00 Phase II/III 12 countries Eyebiotech Limited

Showing 1–2 of 2 trials

← All drugs A–Z